News & Media

Presenting at the Mid-Atlantic Capital Conference in Philadelphia

Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Today, I had the privilege of presenting Calla Lily Clinical Care’s latest innovation, Callavid®, at the MidAtlantic Capital Conference with PACT in Philadelphia. It’s an exciting step forward in women’s health, particularly for those navigating the challenges of IVF and miscarriage.

Our Callavid technology harnesses the power of intravaginal drug delivery initially through our medical device impregnated with progesterone. By doing this, we take the pain out of IVF, reduce the uncertainty of medication administration, and dramatically improve both comfort and compliance.

Sharing Calla Lily’s story and my personal journey with IVF today has been incredibly meaningful. This work isn’t just a professional mission—it’s deeply personal. I’m thrilled to be part of a movement that supports women’s health in ways that matter.

我們使用 cookies 來增強您的網站體驗。我們使用必要的 cookies 來確保我們的網站功能正常,並保持其安全性。這些 cookies 需要一直開啟。透過點擊「接受 Cookies」,同意Cookies 儲存您的設備,以增強網站導航,分析網站使用情況,並協助我們的營銷工作。請參閱我們的私隱政策獲取更多詳情。